ArticleJournal of cancer research and clinical oncology2023

Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.

Timothy J Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.